Friedrich Feuerhake

11PUBLICATIONS
149CO-AUTHORS
Predictive and prognostic markersArtificial life and complex adaptive systemsMedical infection agents (incl. prions)MechanobiologyNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 03, 2025
Multiomic Factor Analysis for Pathologic Complete Response after Pembrolizumab + Trastuzumab + Pertuzumab in HER2-Enriched Early Breast Cancer: WSG-Keyriched-1 Trial.

Monika Graeser, Oleg Gluz, Peter Schmid

|Apr 14, 2023
Proinflammatory Macrophage Activation by the Polysialic Acid-Siglec-16 Axis Is Linked to Increased Survival of Patients with Glioblastoma.

Hauke Thiesler, Lina Gretenkort, Leonie Hoffmeister

|Nov 28, 2022
Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial.

Monika Graeser, Oleg Gluz, Claudia Biehl

|Oct 31, 2022
Understanding fibrosis pathogenesis via modeling macrophage-fibroblast interplay in immune-metabolic context.

Elisa Setten, Alessandra Castagna, Josué Manik Nava-Sedeño

Pageof 2